Company intelligence / Profile preview

Amishi Drugs and Chemicals

Ahmedabad, Gujarat, India
Ownership
Private
Employees
~150
Development stage
Other
01

Overview

Amishi Drugs and Chemicals was an Indian manufacturer and exporter of pharmaceutical excipients and drug substances (APIs) including microcrystalline cellulose and silver sulfadiazine. Headquartered in Ahmedabad, Gujarat, and founded in 1983, the company was known for its product quality, international certifications, and diversified excipient portfolio. It served global and Indian pharmaceutical companies until its acquisition by Ingredion in 2022.

Modalities
Small moleculeExcipient
Industry
Contract Manufacturing Organization

Beyond the preview

Go deeper on Amishi Drugs and Chemicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amishi Drugs and Chemicals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call